Multi-modality Imaging Identifies Key Times for Annexin V Imaging as an Early Predictor of Therapeutic Outcome
Radiolabeled annexin V may provide an early indication of the success or failure of anticancer therapy on a patient-by-patient basis as an in vivo marker of tumor cell killing. An important question that remains is when, after initiation of treatment, should annexin V imaging be performed. To addres...
Main Authors: | Stefanie J. Mandl, Carina Mari, Matthias Edinger, Robert S. Negrin, Jonathan F. Tait, Christopher H. Contag, Francis G. Blankenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2004-01-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.1162/15353500200403157 |
Similar Items
-
Breaching Biological Barriers: Protein Translocation Domains as Tools for Molecular Imaging and Therapy
by: Benjamin L. Franc, et al.
Published: (2003-10-01) -
Comparative analysis among therapeutic modalities in ruptured hepatocellular carcinoma and identification of imaging predictors for survival
by: Natthaphong Nimitrungtawee, et al.
Published: (2024-08-01) -
Therapeutic Potential of Annexins in Sepsis and COVID-19
by: Louise Mui, et al.
Published: (2021-09-01) -
Noninvasive Assessment of Tumor Cell Proliferation in Animal Models
by: Matthias Edinger, et al.
Published: (1999-10-01) -
Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of Tc-Hynic-rh-Annexin V Imaging
by: M.S. Kartachova, et al.
Published: (2008-01-01)